Brent Ragans


Brent Ragans is responsible for Ferring US commercial, manufacturing and development operations.

Brent has more than 25 years of experience in the pharmaceutical industry. Before joining Ferring in 2012, he built and led several multi-billion dollar brands for Sanofi, where his last position was Senior Vice President of North American Consumer Healthcare Strategy and Corporate Development. Brent began his career at Bock Pharmaceuticals.

Brent holds a Bachelor of Science degree in Legal Communications and Marketing from Florida State University. 

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience. ORTIKOS is a trademark of Sun Pharma Global FZE.

©2008-2020 Ferring Pharmaceuticals.  US-CORP-2100028